Corcept Therapeutics is trading at $116.77, up 4.17%, amid biotech-sector strength.
- No clear company-specific announcement dated October 20, 2026, emerged in available coverage; the investor-relations page lists September 18 as its latest release.
- XBI is up 2.10%, with sector sentiment supported by Merck’s acquisition of Silence Therapeutics.
- Intraday volume or activity data was not available in the cited sources.